FLT3 inhibitor TG101209, Purity ≥98%

Cat. No.: X23-10-ZQ187

FLT3 inhibitor TG101209, Purity ≥98%

Synonym: 936091-14-4; TG101209; TG-101209; TG 101209; N-tert-Butyl-3-(5-methyl-2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-ylamino)benzenesulfonamide; N-tert-Butyl-3-[[5-methyl-2-[4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide; FLT3 inhibitor

  • MDL: MFCD15528085
  • CAS Number: 936091-14-4
  • Compound CID: 16722832
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
TG101209, soluble in DMSO and insoluble in ethanol and water, is a protein tyrosine kinase inhibitor that has shown potent biochemical activity against FLT3. It targets JAK2, RET, FLT3, and JAK3.
Molecular Weight
509.67
Molecular Formula
C26H35N7O2S
Targets
JAK2: 6 nM; RET: 17 nM; FLT3: 25 nM; JAK3: 169 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 94 mg/mL (184.42 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
TG101209 can be used to explore the inhibition of JAK2 and its potential therapeutic applications in myeloproliferative disorders.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0